Weizmann Institute-Born Cell Therapy Technology In Clinical Trials for ALS Patients
Kadimastem, an Israeli biopharma venture, recently declared it was hoping to discuss with the U.S. Food and Drug Administration (FDA) […]
Kadimastem, an Israeli biopharma venture, recently declared it was hoping to discuss with the U.S. Food and Drug Administration (FDA) […]
The AMG Center for ALS at Mass General recently announced, along with Amylyx Pharmaceuticals, Inc., that AMX0035 demonstrated a significant treatment […]
The ALS Never Surrender Foundation, a volunteer-based, non-profit organizations on a mission to cure Motor Neuron Disease and Amyotrophic Lateral […]
University of Arizona researchers have identified that increasing glucose, transformed into energy, can potentially give people afflicted with amyotrophic lateral […]
A Southern Research Scientist’s early-stage work on potential new therapies for amyotrophic lateral sclerosis (ALS) is getting a push thanks […]
A recent Phase 1 clinical trial involving the injection of human lateral sclerosis (ALS) was found safe and did not […]
MedicalXpress reports that the Barrow Neurological Center researchers discovered that a specific RNA processing protein, known as ADAR2, undergoes cellular […]
Columbia University and Project ALS today announced the Project ALS Therapeutics Core at Columbia, a 3-year, $6.3M initiative toward the first meaningful therapies […]
WMC 5 News showcases Dr. Mondira Kandu and her research efforts for St. Jude Children’s Research Hospital. Recently her team […]
Institute for EthnoMedicine (the Institute) Brain Chemistry Labs is located in Jackson Hole, Wyoming. Nestled next to the Tetons—a spectacular […]